{"title": "Immunomodulatory Lipids in Plants: Plant Fatty Acid Amides and the Human Endocannabinoid System", "author": "J\u00fcrg Gertsch", "url": null, "hostname": null, "description": "Thieme E-Books & E-Journals", "sitename": "Planta Medica", "date": "2008-05-08", "cleaned_text": "Plants: Plant Fatty Acid Amides and Endocannabinoid System Publikationsverlauf Received: November 12, 2007 Revised: January 9, 2008 Accepted: January 10, 2008 Publikationsdatum: 14. Februar 2008 (online) Abstract Since the discovery that endogenous lipid mediators show similar cannabimimetic effects as phytocannabinoids from Cannabis sativa, our knowledge about the endocannabinoid system has rapidly expanded. Today, endocannabinoid action is known to be involved in various diseases, including inflammation and pain. As a consequence, the G-protein coupled cannabinoid receptors, endocannabinoid transport, as well as endocannabinoid metabolizing enzymes represent targets to block or enhance cannabinoid receptor-mediated signalling for therapeutic intervention. Based on the finding that certain endocannabinoid-like fatty acid CB2 cannabinoid receptors we our interest on plant fatty acid amides (FAAs) and their overall cannabinomodulatory effects. Certain FAAs are also able to partially inhibit the action of fatty acid amide hydrolase (FAAH), which controls the breakdown of endocannabinoids. Intriguingly, plants lack CB receptors and do not synthesize endocannabinoids, but express FAAH homologues capable of metabolizing plant endogenous N-acylethanolamines (NAEs). While the site of action of these NAEs in plants is unknown, endogenous NAEs and arachidonic acid glycerols in animals interact with distinct physiological lipid receptors, including cannabinoid receptors. There is increasing evidence that also plant FAAs other than NAEs can pharmacologically modulate the action of these endogenous lipid signals. The interference of plant FAAs with the animal endocannabinoid system could thus be a fortunate evolutionary cross point with yet unexplored therapeutic potential. Key words Echinacea - endocannabinoid system - acid - [1 Fahy E, Subramaniam S, Brown H A, Glass C K, Merrill AH J r, Murphy R C. et al . A comprehensive classification system for lipids. J Lipid Res. 2005; 46 839-61] - [2 Aguilar P S, de Mendoza D. Control of fatty acid desaturation: a mechanism conserved from bacteria O. the discovery of essential fatty acids. J Nutr. 1988; 118 535-40] - [5 Vane J R. Antiinflammatory drugs and the many mediators of inflammation. Int J Tissue React. 1987; 9 1-14] - [6 Vane J R, Botting R M. The mode of action of anti-inflammatory drugs. Postgrad Med J. 1990; 66 (Suppl.) S2-17] - Higgs G A, Moncada S, Vane J R. Eicosanoids in inflammation. Ann Clin Res. 1984; 16 287-99] - [8 Baker R R. eicosanoids: - [10 Demopoulos C A, Antonopoulou S. A discovery trip to compounds with PAF-like activity. Exp Med Biol. 1996; 416 59-63] - Sakane S, Kai M, Yasuda S, Kanoh H. Diacylglycerol kinases: - S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T. Identification of GPR55 as a lysophosphatidylinositol GPR55: a new member of the cannabinoid receptor clan?. Br J Pharmacol 2007, in press] - [15 Ghosh S, Strum J C, Bell R M. Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling. FASEB J. 1997; 11 45-50] - [16 Serhan C N. Novel chemical M emerging field of lipidomics. Nat Rev Drug Discov. 2005; 4 594-610] - [18 Fritsche K. Fatty Rev Nutr. 2006; 26 45-73] - [19 de Pablo M A, Puertollano M A, Alvarez de Cienfuegos G. Biological and clinical significance of lipids as modulators of immune system functions. Clin Diagn Lab Immunol. 2002; 9 945-50] - [20 Brown A J. Novel cannabinoid receptors. Br J Pharmacol 2007, in press] - [21 K, T S, Kochetova M M, Khalilov E M. Lysophospholipid receptors in cell signaling. Biochemistry (Moscow). 72 [25 J B, Gillies L A, Smilowitz J T, Zivkovic A M, Watkins S M. Lipidomics and lipid profiling M. The phylogenetic of D. Plant, synthetic, and endogenous cannabinoids in medicine. Annu Rev Med. 2006; 57 553-74] - [28 Kogan N M, Mechoulam R. chemistry Endocrinol Invest. 2006; 29 3-14] - [29 G. The diverse of three plant cannabinoids: Pavlopoulos Thakur G A, Nikas S Makriyannis Cannabinoid receptors as therapeutic 12 1751-69] - [31 Mechonlam R, Gaoni Y. Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic - [33 Devane W A, Dysarz FA 3 rd, Johnson M R, Melvin L S, Howlett A C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34 605-13] - [34 Herkenham M, Lynn A B, de Costa B R, Richfield E K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 1991; 547 267-74] - [35 Matsuda L A, Lolait S J, Brownstein M J, Young A C, Bonner T I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346 561-4] - [36 Munro S, Thomas K L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993; 365 61-5] W A, Dysarz FA 3 rd, Johnson M R, Melvin L S, Howlett A C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34 605-13] - [39 Ward S E, Bell M, Childers S, DAmbra T, Eissenstat M. et al . 1990; 105 425-6] - [40 Herkenham M, Lynn A B, Little M D, Johnson M R, Melvin L S. et al . Cannabinoid receptor localization in brain. Proc 87 1932-6] P, Vanderhaeghen J J. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol. 2005; 78 1192-7] - [43 Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol. 2005; 168 299-325] - [44 Gong J P, Onaivi E S, Ishiguro H, Liu Q R, Tagliaferro P A, Brusco A. et al . Cannabinoid CB2 1071 10-23] - [45 Onaivi E S, Ishiguro H, Gong J P, Patel S, Perchuk A, Meozzi P A. et al . Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci. 2006; 514-36] - [46 Howlett T I, Cabral G, Casellas P, Devane W A. et al . International Union of Pharmacology, XXVII. Classification of 549-63] Devane W A, Hanus L, Breuer A, Pertwee R G, Stevenson L A, Griffin G. et al . Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992; 258 1946-9] - [50 Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J C. et al . Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994; 372 686-91] - [51 Thomas B F, Adams I B, Mascarella S W, Martin B R, Razdan R K. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid Med Chem. 1996; 39 471-9] - [52 Y, Wang J, 1998; 359 1-18] - [55 Klein T W, Newton C, Larsen K, Lu L, Perkins I, Nong L. et al . The cannabinoid system and immune 74 486-96] - [56 Pertwee R G. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J. 2005; 7 E625-54] - [57 Hanus L O. Discovery and isolation of anandamide and endocannabinoids. Chem Biodivers. 2007; 4 1828-41] - Kogan chemistry endocannabinoids. Endocrinol Invest. 2006; 3-14] A, Cadas H, Schinelli S, Cimino G, Schwartz J C. et al . Formation and inactivation of endogenous cannabinoid anandamide in central Nature. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci. 1996; 16 3934-42] - [61 Beltramo M, Stella N, Calignano A, Lin S Y, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 1997; 277 1094-7] - [62 Cravatt B F, Giang D K, Mayfield S P, Boger D L, Lerner R A, Gilula N B. Molecular characterization of an J, Schumacher M A, Tominaga M, Rosen T A, Levine J D, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997; 389 816-24] - [64 Akerman S, Kaube H, J. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 Br Pharmacol. Hermansson N O, Leonova J. et al . The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007; 152 1092-110] - [66 Brown A J. Novel Br Pharmacol. 152 Moriello A S, M G, De Petrocellis L. et al . Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. J Med Chem. 2006; 49 2333-8] - [68 Appendino G, Cascio M G, Bacchiega S, Moriello A S, Minassi A, Thomas A. et \"hybrid\" Further advances in the synthesis of endocannabinoid-related ligands. AAPS J. 2005; 7 E496-502] - R. chemistry Invest. 2006; 29 3-14] - [71 Raduner S, Majewska A, Chen J Z, Xie X Q, Hamon J, Faller B. et al . Alkylamides from Echinacea are a new class of cannabinomimetics. type 2 receptor-dependent and -independent immunomodulatory [72 Gertsch Khan I, Altmann K -H, Gertsch J. Exploration of natural and synthetic N-alkyl amides as source for new lead structures to target the endocannabinoid system. ICRS meeting 2007, Saint Sauveur, G, Ramirez-Chavez E, Herrera-Estrella signals plant Curr Opin Plant Biol. 2006; 9 523-9] - [75 Chapman K D. Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants. Prog Lipid Res. 2004; 43 302-27] - [76 Doskotch R W, Beal J L. The isolation and identification of the numbing principle in Chrysanthemum anethifolium. Lloydia. 1970; 33 393-4] - Worth J, Waibel R, Portecop J. Constituents of tropical medicinal plants, IXX1 GC/MS-investigations of the constituents of Piper amalago - 30 new amides of the piperine-type. Probstle Redl Greger Bauer R. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides 60 - [79 Ramsewak S, Erickson A J, Nair M G. Bioactive N-isobutylamides from the flower R, Nishioka A. Chemical constituents of peppers (Piper spp.) and application to food preservation: naturally occurring compounds. Environ Health Perspect. 1986; 67 135-42] - [82 Muhammad I, Zhao J, Dunbar D C, Khan I A. Constituents of Lepidium meyenii 'maca'. Phytochemistry. 2002; 59 105-10] - [83 Zhao J, Muhammad I, Dunbar D C, Mustafa J, Khan I A. New alkamides from maca (Lepidium meyenii). J Agric Food Chem. 2005; 53 690-3] - [84 Pei Y Q. A review of pharmacology and clinical use of piperine and its derivatives. Epilepsia. 1983; 24 177-82] - [85 Greger H. Alkamides: structural distribution and biological activity. Planta Med. 1984; 50 366-75] - [86 Bauer R, Remiger P, Wagner H. New alkamides from Echinacea angustifolia and Nat Prod. 1998; 61 681-4] - [89 Avery T D, Culbert J A, Taylor D K. The first total synthesis of natural grenadamide. Org Biomol Chem. 2006; 4 323-30] - [90 Chapman K D. Emerging physiological roles for N-acylphosphatidylethanolamine metabolism in plants: signal transduction and protection. Chem Phys Lipids. 2000; 221-9] [91 Chapman S, Venables B, Desouza A D. N-Acylethanolamines: formation and molecular composition of a new class of plant lipids. Plant Physiol. 1998; 116 1163-8] - [92 Chapman K D. Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants. Prog Lipid Res. 2004; 43 J, Herrera-Estrella L, Molina-Torres J. Alkamides isolated from plants promote growth and alter root development in Arabidopsis. Plant Physiol. Ramirez-Chavez E, Molina-Torres J. et al .Cytokinin receptors are involved in alkamide regulation of root and shoot development in Arabidopsis thaliana. Plant Physiol 2007, in press] - [95 S, Shrestha R, Kilaru A, Wiant W, Venables B J, Chapman K D. et al . Manipulation of Arabidopsis fatty acid amide hydrolase expression growth to N-acylethanolamines. Proc Natl Acad Sci USA. [96 Jonsson K O, Vandevoorde S, Lambert D M, Tiger G, Fowler C J. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the anandamide. Br J Pharmacol. 2001; 133 1263-75] - [97 McKinney M K, Cravatt B F. Structure-based design of a FAAH variant that discriminates between the ethanolamine - Woelkart K, Xu W, Pei Y, Makriyannis A, Picone R P, Bauer R. The endocannabinoid system as a target for alkamides from Echinacea Planta F, A. Insecticidal amides from fruits of Piper nigrum Nat Prod 19 143-50] - [100 Zlotkin E. The insect voltage-gated channel target insecticides. Annu Rev Entomol. 1999; 44 429-55] - [101 Tsao R, Marvin C H, Broadbent A B, Friesen M, Allen W R, McGarvey B D. Evidence for an isobutylamide associated with host-plant resistance to western flower thrips, Frankliniella occidentalis, in chrysanthemum. J Chem Ecol. 2005; 31 103-10] - [102 Wakamatsu K, Masaki T, Itoh F, Kondo K, Sudo K. Isolation of fatty acid amide as an Commun. 1990; 423-9] - [103 Jaffe K, Blum M S, Fales H, Mason R, Cabrera A. On insect attractants from pitcher plants of the genus Heliamphora Chem Ecol. 1995; G, Gilula N B, Henriksen S J, Boger D L. et al . Chemical characterization of a family of brain lipids that induce sleep. Science. 1995; 268 1506-9] - [105 Huitron-Resendiz S, Gombart L, Cravatt B F, Henriksen S J. Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol. 2001; Venables B J, Tripathy S, Mysore K S, Chapman K D. The N-acylethanolamine-mediated regulatory pathway in plants. Chem Biodivers. 2007; 4 al Abscisic endogenous cytokine in ADP-ribose as Natl 2007; di Tomaso E, Beltramo M, D. chocolate. 1996; 677-8] [109 Tytgat J, Van Boven M, Daenens P. Cannabinoid mimics in chocolate utilized as an argument in court. Int J Legal Med. 2000; 113 137-9] - [110 Ueda N, Yamanaka K, Yamamoto S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory Movahed B Birnir B, Wingstrand J 280 38 496-504] - [112 Matthias A, Addison R S, Penman K G, Dickinson R G, Bone K M, Lehmann R P. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion. Life Sci. 2005; 77 2018-29] - [113 Woelkart K, Koidl C, Grisold A, Gangemi J D, Turner R B, Marth E. et al . Bioavailability and pharmacokinetics of alkamides from the Prod. 2007; 70 1010-5] - [115 Barnes J, Anderson L A, Gibbons S, Phillipson J D. Echinacea species (Echinacea angustifolia (Nutt.) Nutt., purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2005; 57 929-54] - [116 Woelkart K, Bauer R. The role of alkamides as an active principle of Echinacea. Planta Med. 2007; 73 615-23] - [117 De Petrocellis L, Di Marzo V. Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci. 2005; 77 1651-66] - [118 Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T. et al . Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Br J Pharmacol. 2003; 140 1351-62] - Alkamides 360 441-6] - LaLone A, Hammer K D, Wu L, Bae J, Leyva N, Liu Y. et al . Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells. J Agric Food Chem. 2007; 55 7314-22] - [122 Hamer R R, Tegeler J J, Kurtz E S, Allen R C, Bailey S C, Elliott M E. et al . Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity. J Med Chem. 1996; 39 246-52] - [123 Suzuki T, Miyata N. Lichtman A H. Fatty acid amide hydrolase: an emerging therapeutic in Opin Chem Biol. 2003; 7 469-75] Lin S, Khanolkar A D, Fan P, Goutopoulos A, Qin C, Papahadjis D. et al . Novel analogues of arachidonylethanolamide (anandamide): for the CB1 and CB2 cannabinoid receptors and metabolic stability. J Med Chem. 1998; 41 5353-61] - [126 Chen Y, Fu T, Tao T, Yang J, Chang Y, Wang M. et al . Macrophage activating effects of new alkamides from the roots of Echinacea species. J Nat Prod. 2005; 68 773-6] - [127 Baldwin G C, Tashkin D P, Buckley D M, Park A N, Dubinett S M, Roth M D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med. 1997; 156 1606-13] - [128 Klein Cannabinoid-based Nat Rev Immunol. 2005; 5 400-11] - [129 Klein T W, Newton C, Widen R, Friedman H. Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice Oka S, Gokoh M, Waku K, Sugiura T. 2-Arachidonoylglycerol, an endogenous ligand, 2004; 135 517-24] - [131 Sasagawa M, Cech N B, Gray D E, Elmer G W, Wenner C A. Echinacea alkylamides inhibit interleukin-2 production by Jurkat cells. Int 2006; 6 1214-21] - [132 H. Amsterdam, Oxford, New York; Elsevier 1988] - [133 Bryant B P, Mezine I. that produce tingling paresthesia activate tactile and 452-60] - [134 Sugai E, Morimitsu Y, Iwasaki Y, Morita A, Watanabe T, Kubota K. Pungent qualities of sanshool-related compounds evaluated by a sensory test and activation of rat TRPV1. Biosci Biotechnol Biochem. 2005; 69 1951-7] Bauer R, Woelkart K, Hulsey T C, Gangemi J D. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 353 341-8] - [136 Schoop R, Klein P, Suter A, Johnston S L. Echinacea in the prevention of rhinovirus Ther. 2006; 28 174-83] - [137 Meadows D C, Mathews T B, North T W, Hadd M J, Kuo C L, Neamati N. et al . Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors. J Med Chem. 2005; 48 4526-34] - [138 Jia C, Shi H, Wu X, Li Y, Chen J, Tu P. Determination of echinacoside in rat serum by reversed-phase high-performance liquid chromatography with ultraviolet detection and its application pharmacokinetics and bioavailability. J Chromatogr B [139 B, Steinmuller C, Gifford G E, Wagner H, Lohmann-Matthes M L. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell of 13 688-94] - [141 Bauer R. New knowledge regarding the effect and effectiveness of Echinacea purpurea extracts. Wien . Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system. Int J Clin Pharmacol Ther. 2006; 44 401-8] - [143 [144 Jones J D, Dangl J L. The plant immune system. Nature. 2006; 444 323-9] - [145 de Wit P J. How plants recognize pathogens and defend themselves. Cell Mol Life Sci 2007, in press] - [146 McPartland J M, Norris R W, Kilpatrick C W. Coevolution between cannabinoid receptors and endocannabinoid ligands. McPartland J M, Matias I, Di Marzo V, Glass M. Evolutionary origins of the endocannabinoid system. Gene. 2006; 370 64-74] - [148 Jonsson K O, Vandevoorde S, Lambert D M, Tiger G, Fowler C J. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the J Pharmacol. 2001; 133 N, Matthias A, Gertsch J, Raduner S, Bone K M, Lehmann R P. et al . Stereoselective synthesis, natural occurrence and CB(2) receptor binding affinities of alkylamides from herbal medicines such as Echinacea sp. Org Biomol Chem. 2007; 5 169-74] [J\u00fcrg Gertsch] of "}